6-K

FINAL COURT APPROVAL CONCLUDES ANTITRUST MDL

Company: Indivior Pharmaceuticals, Inc.
Filed: February 29, 2024
Period of Report: February 29, 2024
Accession Number: 0001654954-24-002340

View Document ↗ View on SEC.gov ↗